Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript November 14, 2023
Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.31.
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2023 Earnings Conference Call. As a reminder, this conference is being recorded. Now, I would like to turn the call over to Jeff Cohen, Executive Director, Assistant General Counsel and...
